This essential reading provides readers with a round-up of news on the latest events relating to our exciting pan-European study on diabetes in older people – read it here [1]. The newletter provides information on the recruitment status of the study, introduces new team members and summarises the various contributions to the programme being made by our partner organisations.
The study website provides a full study update [2].In brief, this far the study has 47 sites that are currently active and 275 subjects have been recruited:
The newsletter also gives a summary of a successful meeting held in Rotterdam. The meeting served as a useful opportunity to introduce new members of the team, be updated on progress in the study and to discuss the next steps in this exciting project. The main outcome of the meeting was the importance of improving recruitment over the next few months; the deadline for completing recruitment is 31 March 2015.
References
Experience at Niche has taught us that clinical study protocols are born in the white-hot fire
Every year, a huge amount of scientific data is released. It's out there, but how do you find it?
Have you seen our latest Insider's Insight on Case Reports? Once a staple of medical journals,
Investigator sites are very important to clinical studies because they make sure that new drugs are safe and work well.
Investigator-Initiated Clinical Trials (IITs) are clinical studies led by academic researchers or clinicians
The clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer,
The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)
The largest pharmaceutical companies not surprisingly rely on the largest contract research organizations
Frights create a happy Halloween by providing the thrill of fear in a controlled and safe environment, turning what.
Concerns about readiness of the European Medicines Agency’s (EMA) Clinical Trials Information System persist as the.
It was encouraging to see so many partners at the 2017 General Assembly meeting last December
When I was younger, the opening lines of the Beatle’s seminal ‘Sgt. Pepper’s Lonely Hearts Club Band’ resonated.
Welcome to the seventh issue of the Refractory Asthma Stratification Programme (RASP-UK) newsletter
I am shamelessly referencing our Insider’s Insights (IIs) to Dr Who’s TARDIS – our latest edition
Rational Vaccines (RVx) announces MHRA Innovation Licensing and Access Pathway (ILAP) approval for their live attenuated.
The UK's world-class human challenge study gives us new information about SARS-CoV-2 cases that were mild in 36 healthy.
Advisory board meetings are often used to address perceived knowledge gaps and build consensus.
Get our latest news and publications
Sign up to our news letterResources
Social
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
